Revisiting Nitrofurantoin for Vancomycin Resistant Enterococci
نویسندگان
چکیده
منابع مشابه
Nitrofurantoin is active against vancomycin-resistant enterococci.
The activity of nitrofurantoin was tested against 300 isolates of Enterococcus faecium, Enterococcus faecalis, and Enterococcus gallinarum. No isolates tested were resistant to nitrofurantoin (MIC, >/=128 microg/ml), including vancomycin-resistant E. faecium isolates with vanA- and vanB-positive genotypes and vancomycin-resistant E. gallinarum isolates. We conclude that nitrofurantoin may provi...
متن کاملVancomycin-resistant enterococci.
Enterococci, a part of normal gut flora, are not particularly pathogenic organisms in humans. For example, they do not cause respiratory tract infections. The most frequent enterococcal infections are urinary tract infections. Despite their lack of pathogenicity, enterococci have emerged as significant nosocomial pathogens in the United States and elsewhere. Enterococci are formidable pathogens...
متن کاملVancomycin-resistant enterococci.
After they were first identified in the mid-1980s, vancomycin-resistant enterococci (VRE) spread rapidly and became a major problem in many institutions both in Europe and the United States. Since VRE have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available antibiotics, either by mutation or by receipt of foreign g...
متن کاملVancomycin-resistant enterococci in hospitals
The future of the CDS Registrants as CDS users continue to grow and number over 200 at present. The CDS method is now being used by laboratories in South East Asia, India and South Africa. It is unfortunate that a number of Australian public laboratories have changed from using the CDSmethod to othermethods as a result of executive decisions apparently based on reasons other than scientific mer...
متن کاملVancomycin-resistant Enterococci, Mexico City
To the Editor: Vancomycin-resistant Enterococcus (VRE) has become an important nosocomial pathogen because of its rapid spread, limited therapy options, mortality, and the possibility of transfer of vancomycin resistance to other pathogens such as Staphylococcus aureus. Vancomycin-resistant E. faecium (VREF) and E. faecalis were fi rst described in 1988 (1,2).They have become major noso-comial ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
سال: 2017
ISSN: 2249-782X
DOI: 10.7860/jcdr/2017/25140.10140